Modern Healthspan: The AI-Designed Molecule That Pees Out Arterial Plaque
Peer-Reviewed Research
Key Takeaways
- UDP-003 is a new drug that physically removes arterial plaque by targeting toxic 7-ketocholesterol, not just lowering LDL cholesterol.
- Unlike statins, this drug reactivates macrophages to clean plaque from inside artery walls, potentially reversing cardiovascular damage.
- Phase 1 human trials by Cyclarity showed success—watch for updates on FDA approval and wider availability.
Notable Quotes
“This marks a massive shift from just managing cardiovascular risk to actively reversing the structural damage of biological aging.”
Bottom Line
Stay informed about UDP-003 as it progresses through clinical trials—this could be a groundbreaking alternative to statins for plaque removal.
Explore More
- Modern Healthspan’s Full Protocol — supplements, dosages, and daily routine
- Compare All Protocols — side-by-side protocols
Watch the Full Video
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. The research summaries presented here are based on published studies and should not be used as a substitute for professional medical consultation. Always consult a qualified healthcare provider before making any changes to your health regimen.
Peer-reviewed health research, simplified. Early access findings, clinical trial alerts & regulatory news — delivered weekly.
No spam. Unsubscribe anytime. Powered by Beehiiv.
Related Research
From Our Research Network
Daily longevity researchZone2 Training
Exercise protocolsSleep Science
Sleep optimization
Part of the Evidence-Based Research Network